CN Patent

CN105061506B — 抗肿瘤药物ap26113的制备方法

Assigned to Shaoxing baiweikang Biotechnology Co.,Ltd. · Expires 2017-08-29 · 9y expired

What this patent protects

本发明揭示了一种抗肿瘤药物AP26113(I)的制备方法，其制备步骤包括：N‑[2‑甲氧基‑4‑[4‑(二甲基氨基)哌啶‑1‑基]苯胺]胍依次与N，N‑二甲氨基丙烯酸酯、4‑(二甲基亚磷酰)苯胺和氯化剂发生环合反应、缩合反应以及氯化反应制得AP26113(I)。该制备方法原料易得，副反应少，经济环保，适合工业化生产。

USPTO Abstract

本发明揭示了一种抗肿瘤药物AP26113(I)的制备方法，其制备步骤包括：N‑[2‑甲氧基‑4‑[4‑(二甲基氨基)哌啶‑1‑基]苯胺]胍依次与N，N‑二甲氨基丙烯酸酯、4‑(二甲基亚磷酰)苯胺和氯化剂发生环合反应、缩合反应以及氯化反应制得AP26113(I)。该制备方法原料易得，副反应少，经济环保，适合工业化生产。

Drugs covered by this patent

Patent Metadata

Patent number
CN105061506B
Jurisdiction
CN
Classification
—
Expires
2017-08-29
Drug substance claim
No
Drug product claim
No
Assignee
Shaoxing baiweikang Biotechnology Co.,Ltd.
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.